Sökning: WFRF:(Kjekshus E) >
International Geogr...
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction
-
Kristensen, S. L. (författare)
-
Kober, L. (författare)
-
Jhund, P. S. (författare)
-
visa fler...
-
Solomon, S. D. (författare)
-
Kjekshus, J. K. (författare)
-
McKelvie, R. S. (författare)
-
Zile, M. R. (författare)
-
Granger, C. B. (författare)
-
- Wikstrand, John, 1938 (författare)
- Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
-
Komajda, M. (författare)
-
Carson, P. E. (författare)
-
Pfeffer, M. A. (författare)
-
- Swedberg, Karl, 1944 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
Wedel, Hans (författare)
-
Yusuf, S. (författare)
-
McMurray, J. J. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2015
- 2015
- Engelska.
-
Ingår i: Circulation. - 1524-4539. ; 131, s. 43-53
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: -International geographic differences in outcomes may exist for clinical trials of heart failure and reduced ejection fraction (HF-REF), but there are few data for those with preserved ejection fraction (HF-PEF). METHODS AND RESULTS: -We analyzed outcomes by international geographic region in the Irbesartan in Heart Failure with Preserved systolic function trial (I-Preserve), the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM)-Preserved trial, the CHARM-Alternative and CHARM-Added HF-REF trials, and the Controlled Rosuvastatin Multinational Trial in HF-REF (CORONA). Crude rates of heart failure hospitalization varied by geographic region, and more so for HF-PEF than for HF-REF. Rates in patients with HF-PEF were highest in the United States/Canada (HF hospitalization rate 7.6 per 100 patient-years in I-Preserve; 8.8 in CHARM-Preserved), intermediate in Western Europe (4.8/100 and 4.7/100), and lowest in Eastern Europe/Russia (3.3/100 and 2.8/100). The difference between the United States/Canada versus Eastern Europe/Russia persisted after adjustment for key prognostic variables: adjusted hazard ratios 1.34 (95% confidence interval, 1.01-1.74; P=0.04) in I-Preserve and 1.85 (95% confidence interval, 1.17-2.91; P=0.01) in CHARM-Preserved. In HF-REF, rates of HF hospitalization were slightly lower in Western Europe compared with other regions. For both HF-REF and HF-PEF, there were few regional differences in rates of all-cause or cardiovascular mortality. CONCLUSIONS: -The differences in event rates observed suggest there is international geographic variation in 1 or more of the definition and diagnosis of HF-PEF, the risk profile of patients enrolled, and the threshold for hospitalization, which has implications for the conduct of future global trials.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- heart failure
- hospitalization
- mortality
- ventricular ejection fraction
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kristensen, S. L ...
-
Kober, L.
-
Jhund, P. S.
-
Solomon, S. D.
-
Kjekshus, J. K.
-
McKelvie, R. S.
-
visa fler...
-
Zile, M. R.
-
Granger, C. B.
-
Wikstrand, John, ...
-
Komajda, M.
-
Carson, P. E.
-
Pfeffer, M. A.
-
Swedberg, Karl, ...
-
Wedel, Hans
-
Yusuf, S.
-
McMurray, J. J.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
Circulation
- Av lärosätet
-
Göteborgs universitet